ブラウザの設定でJava Scriptの使用を有効にしてご利用ください。
出典:Wikipedia
出典:『Wikipedia』 (2011/07/24 14:07 UTC 版)
5,6-Methylenedioxy-2-aminoindane (MDAI) is a drug developed in the 1990s by a team led by David E. Nichols at Purdue University. It acts as a non-neurotoxic and highly selective serotonin releasing agent (SSRA) in vitro and produces entactogen effects in humans.
MDAI